Savara

The page offers Savara’s articles, publications, presentations, and posters on ongoing initiatives.

Join a team of highly motivated, compassionate individuals dedicated to improving the lives of patients with rare respiratory diseases.

Dr. An van Es-Johansson joined Savara’s Board of Directors in December 2019. She previously led AlzeCure Pharma and now serves on Plus Therapeutics’ board.

Mr. Ramsay has served as a member of Savara’s Board of Directors since April 2017 and served as a member of the Board of Directors of Mast Therapeutics, Inc. (Savara closed a reverse merger with Mast Therapeutics in April 2017). Mr. Ramsay currently provides consulting services to publicly traded and privately held biotechnology companies and […]

Dr. McCracken has been Savara’s lead independent director since December 2019 and advises biopharmaceutical companies on strategy and business development.

Ms. McCabe became Savara’s Chief Legal Officer in December 2024, having previously served as General Counsel. She previously worked at Wilson Sonsini Goodrich & Rosati.

Savara’s management team has expertise in orphan drug development and pulmonary medicine.

Savara Inc. is based in Langhorne, Pennsylvania, and can be contacted by phone or email.

Savara provides high-quality information on rare respiratory diseases and investigational therapies.

Savara Inc. is a clinical-stage biopharmaceutical company focused on rare respiratory diseases.

Savara’s privacy policy outlines medical information call center procedures for healthcare providers.